Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Assessment of Dysphagia and Its Associations in Patients With Secondary Progressive Multiple Sclerosis Publisher Pubmed



Hamidi M1 ; Rezaeimanesh N1 ; Sahraian MA1 ; Naser Moghadasi A1
Authors

Source: Multiple Sclerosis and Related Disorders Published:2025


Abstract

In this cross-sectional study in patients with secondary progressive multiple sclerosis receiving anti-CD20 monoclonal antibodies, we assessed complaint of dysphagia and evaluated their association with sex, age, disease duration, disability severity, and disease-modifying therapies (DMTs). The validated Persian version of Dysphagia in Multiple Sclerosis (DYMUS) questionnaire was used. A total of 66 patients were included. The median DYMUS score was 1.0 [interquartile range: 0.0-2.3] and 40 (60.6%) had positive DYMUS. Only DMT showed a significant association with DYMUS score, with patients receiving reituximab exhibiting higher scores (mean estimated difference: 0.96 (±0.39), p = 0.014). Grouping patients into positive and negative DYMUS scores, no significant associations were observed (p > 0.05). © 2024 Elsevier B.V.
Related Docs
View other Related Docs
1. Mri Features and Disability in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Neuroradiology (2024)
2. Prevalence and Predictors of Dysphagia in Iranian Patients With Multiple Sclerosis, Medical Journal of the Islamic Republic of Iran (2017)
3. Demographic Features, Behavioral Measures, and Clinical Factors As Predictors of Cognitive Function in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (8)
Sharareh Eskandarieh (5)
Other Related Docs
4. Multiple Sclerosis and Lower Urinary Tract Symptoms: A Survey of Prevalence, Characteristic and Urological Evaluations, SAGE Open Medicine (2023)
5. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
6. Covid-19 and Its Implications on the Clinico-Radiological Course of Multiple Sclerosis: A Case–Control Study; [Covid-19 Y Sus Implicaciones En El Curso Clinico-Radiologico De La Esclerosis Multiple: Un Estudio De Casos Y Controles], Medicina Clinica (2023)
7. Comparable Efficacy and Safety of Teriflunomide Versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis, Neurology Research International (2021)
8. Association of Self-Reported Adherence to the Mediterranean Diet With Anthropometric Indices, Comorbidities, and Degree of Disability in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
9. Potential Efficacy of Caffeine Ingestion on Balance and Mobility in Patients With Multiple Sclerosis: Preliminary Evidence From a Single-Arm Pilot Clinical Trial, PLoS ONE (2024)
10. Anti-Jc Virus Antibody Sera Positivity and Index Value Among Patients With Multiple Sclerosis May Be Correlated With Age, Sex, and Area of Residence, Journal of NeuroVirology (2018)
11. Validity and Reliability of the Persian Version of the Perception De La Scle’Rose En Plaques Et De Ses Pousse’Es Questionnaire Evaluating Multiple Sclerosis-Related Quality of Life, International Journal of Preventive Medicine (2016)
12. A Report of Multiple Sclerosis Registry in Mazandaran Province 2019-2021, Journal of Mazandaran University of Medical Sciences (2022)
13. Efficacy and Safety of Rituximab in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Acta Neurologica Belgica (2023)
14. Evaluating the Efficacy and Safety of Zytuxtm (Rituximab, Aryogen Pharmed) in Iranian Multiple Sclerosis Patients: An Observational Study, Multiple Sclerosis and Related Disorders (2019)
15. Intervening to Reduce the Risk of Future Disability From Multiple Sclerosis: Are We There Yet?, International Journal of Neuroscience (2017)
16. Infectious Agents and Different Course of Multiple Sclerosis: A Systematic Review, Acta Neurologica Belgica (2018)
17. Mizaj Assessment in Multiple Sclerosis (Ms) Patients Based on Persian Medicine, Journal of Complementary and Integrative Medicine (2021)
18. Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review, Neuroepidemiology (2016)
19. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
20. Exploring Autoimmune Endocrine Diseases Induced by Monoclonal Antibodies Used As Multiple Sclerosis Pharmacotherapy: A Systematic Review, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)